Dermira Priced, Nasdaq: DERM.XX
Biotech targeting skin conditions such as psoriasis, excessive sweating and acne.
Industry: Health Care
First Day Return: -2.8%
DERM.XX
Biotech targeting skin conditions such as psoriasis, excessive sweating and acne.
| IPO Data | |
|---|---|
| IPO Date | 10/02/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $125 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Redwood City, CA, United States |
| Founded | 2010 |
| Employees at IPO | 25 |
| Website www.dermira.com | |
IPO News for Dermira
Dermira (DERM.XX) Performance
